Cargando…
PMON126 Null Cell Adenoma With Low Ki-67 Presenting as Recurrent Pituitary Mass
BACKGROUND: Pituitary adenomas account for 10% to 15% of all intracranial masses. Among these, approximately one-third are identified as nonfunctioning pituitary adenomas (NFPA) which have a heterogenous profile and an increased potential for relapse one to five years after pituitary surgery. In a r...
Autores principales: | Tiu, Leo, Montano, Carolyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625533/ http://dx.doi.org/10.1210/jendso/bvac150.1118 |
Ejemplares similares
-
PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022) -
PMON106 Persistent Prolactin Levels in a Patient with Pituitary Adenoma
por: Kadakia, Natasha, et al.
Publicado: (2022) -
PMON170 Treating human primary non-functioning pituitary adenoma cells with cabergoline
por: Begalli, Federica, et al.
Publicado: (2022) -
PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022) -
PMON109 A Case of Non-functioning Pituitary Adenoma With Unexpectedly High Prolactin Level
por: Mahali, Lakshmi Priyanka, et al.
Publicado: (2022)